Vision and mission


Tailored cancer care where TK1 is an integral part.


Increase the utility and use of TK1.

Business concept

AroCell develops, produces, markets, and sells a patented methodology to obtain a measure of the biomarker TK1 in blood.
The biomarker can be used during and after cancer treatment for tailored care.